{"data":{"id":"us/21-cfr-201.6","jurisdiction":"us","citation":"21 CFR 201.6","heading":"Drugs; misleading statements.","body":"(a) Among representations in the labeling of a drug which render such drug misbranded is a false or misleading representation with respect to another drug or a device or a food or cosmetic.\n(b) The labeling of a drug which contains two or more ingredients may be misleading by reason, among other reasons, of the designation of such drug in such labeling by a name which includes or suggests the name of one or more but not all such ingredients, even though the names of all such ingredients are stated elsewhere in the labeling.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER C—DRUGS: GENERAL","PART 201—LABELING","Subpart A—General Labeling Provisions"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"570057ebbe201e842aad50a95ce3b260d5fd357a3ab169d815a5a7b6cf64ebf4","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-201.5","next":"us/21-cfr-201.10"},"notice":"GroundRules: Original legal text. Not legal advice."}